Stimulation of Tolerogenic Dendritic Cells Using Dexamethasone and 1,25‑dihydroxyvitamin D3 Represses Autologous T Cell Activation and Chondrocyte Inflammation

Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2018.7036
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Comparative Transcriptomic Profile of Tolerogenic Dendritic Cells Differentiated With Vitamin D3, Dexamethasone and Rapamycin

Scientific Reports
Multidisciplinary
2018English

Points: 1,25 Dihydroxyvitamin D3 in Psoriasis

BMJ
1986English

1,25-Dihydroxyvitamin D3 and Cisplatin Synergistically Induce Apoptosis and Cell Cycle Arrest in Gastric Cancer Cells

International Journal of Molecular Medicine
MedicineGenetics
2014English

Regulatory Effects of 1,25-Dihydroxyvitamin D3 on Vascular Smooth Muscle Cells.

Acta Biochimica Polonica
BiochemistryGeneticsMolecular Biology
2012English

Analysis of 1,25-Dihydroxyvitamin D3 Receptors (VDR. In Basal Cell Carcinomas

American Journal of Pathology
Forensic MedicinePathology
1999English

Synergistic Effect of 1,25-Dihydroxyvitamin D3 and Retinoic Acid in Inducing U937 Cell Differentiation.

Journal of Nutritional Science and Vitaminology
MedicineNutritionDietetics
1992English

Defective Binding and Function of 1,25-Dihydroxyvitamin D3 Receptors in Peripheral Mononuclear Cells of Patients With End-Organ Resistance to 1,25-Dihydroxyvitamin D.

Journal of Clinical Investigation
Medicine
1985English

Paracrine Interactions Between Mesenchymal Stem Cells and Macrophages Are Regulated by 1,25-Dihydroxyvitamin D3

Scientific Reports
Multidisciplinary
2017English

Induction of Monocytic Differentiation and Bone Resorption by 1,25-Dihydroxyvitamin D3.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1983English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy